Recro Pharma, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • May 13th, 2021 • Recro Pharma, Inc. • Pharmaceutical preparations • New York
Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of 13,333,333 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 1,999,999 additional shares (the “Optional Securities”) of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
